SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-042512
Filing Date
2019-11-12
Accepted
2019-11-12 06:57:10
Documents
58
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q reta-10q_20190930.htm   iXBRL 10-Q 2154060
2 EX-10.1 reta-ex101_12.htm EX-10.1 148150
3 EX-10.2 reta-ex102_13.htm EX-10.2 194244
4 EX-10.3 reta-ex103_14.htm EX-10.3 41253
5 EX-10.4 reta-ex104_15.htm EX-10.4 14628
6 EX-31.1 reta-ex311_7.htm EX-31.1 20540
7 EX-31.2 reta-ex312_8.htm EX-31.2 20606
8 EX-32.1 reta-ex321_6.htm EX-32.1 10196
9 EX-32.2 reta-ex322_9.htm EX-32.2 10176
  Complete submission text file 0001564590-19-042512.txt   6144098

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA reta-20190930.xsd EX-101.SCH 35565
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reta-20190930_cal.xml EX-101.CAL 38531
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reta-20190930_def.xml EX-101.DEF 157180
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE reta-20190930_lab.xml EX-101.LAB 303534
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reta-20190930_pre.xml EX-101.PRE 242090
15 EXTRACTED XBRL INSTANCE DOCUMENT reta-10q_20190930_htm.xml XML 742417
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37785 | Film No.: 191205973
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences